Smiths to take FreeStyle to the US:
This article was originally published in Clinica
Smiths Medical is set to market and distribute Abbott's recently FDA-approved FreeStyle Navigator continuous glucose monitoring system in the US. The non-exclusive distribution deal will see Smiths add the FreeStyle Navigator system to its diabetes product portfolio, which includes the CozMore "all-in-one" blood glucose monitoring and insulin pump system, and the Deltec Cozmo insulin pump. The FreeStyle Navigator system, approved by the FDA in March, is designed to improve diabetes management by continually recording interstitial fluid glucose levels through a sensor worn under the patient's skin for five days. Financial terms of the deal were not disclosed.
You may also be interested in...
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.
The FDA has released final guidance on “Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA” for the industry. The guidance brings clarity and aims at facilitating product development meetings between the FDA and the ANDA applicants for complex products.
By handing out free supplements to the clinically vulnerable, the UK government is effectively endorsing the use of vitamin D to reduce the risk and/or severity of COVID-19, although it says more research is needed.